Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of an exon 27-skipping antisense oligonucleotide as a targeted therapy for refractory skin ulcers in Werner syndrome.

Molecular therapy. Nucleic acids·2026
Same author

Discovery of a Novel Compound Enhancing SVZ Neurogenic Effects via Human Neural Stem Cell-Based Phenotypic Screening.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Comparative EEG analysis of the effects of ketamine enantiomers and metabolites in rhesus macaques.

Journal of neurophysiology·2026
Same author

Disrupted rest-task shift of multi-band electroencephalography complexity in patients with schizophrenia.

Schizophrenia (Heidelberg, Germany)·2025
Same author

Comparative study of ERP habituation to tones and fearful vocalizations in autism spectrum disorders: a translational biomarker for sensory hypersensitivity.

Molecular psychiatry·2025
Same author

Advanced High-Content Phenotypic Screening to Identify Drugs That Ameliorate the Inhibition of Skeletal Muscle Cell Differentiation Induced by Cancer Cachexia Serum.

Pharmaceuticals (Basel, Switzerland)·2025

Related Experiment Video

Updated: Jun 3, 2026

A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors
10:28

A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors

Published on: August 17, 2019

High-throughput screening for small-molecule adiponectin secretion modulators.

Kyosuke Hino1, Hidetaka Nagata, Manabu Shimonishi

  • 1Genomic Science Laboratories, Dainippon Sumitomo Pharma Co. Ltd., Konohana-Ku, Osaka, Japan.

Journal of Biomolecular Screening
|April 9, 2011
PubMed
Summary
This summary is machine-generated.

Researchers developed a new screening method to find compounds that boost adiponectin, a protein that helps fight metabolic disorders like diabetes and obesity without causing harmful side effects.

More Related Videos

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
09:39

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Published on: January 27, 2014

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Related Experiment Videos

Last Updated: Jun 3, 2026

A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors
10:28

A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors

Published on: August 17, 2019

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
09:39

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Published on: January 27, 2014

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Area of Science:

  • Endocrinology
  • Metabolic Research
  • Drug Discovery

Background:

  • Adiponectin, an adipokine from adipocytes, suppresses metabolic disorders including type 2 diabetes, obesity, and atherosclerosis.
  • Upregulation of adiponectin offers therapeutic benefits for metabolic syndromes.
  • Peroxisome proliferator-activated receptor γ (PPARγ) agonists increase adiponectin but cause adverse effects like edema and heart failure.

Purpose of the Study:

  • To develop a high-throughput screening (HTS) assay for identifying adiponectin secretion modulators.
  • To discover novel compounds that increase adiponectin without PPARγ agonistic activity.

Main Methods:

  • Development of a reporter-based HTS assay using insulin-resistant 3T3-L1 adipocytes.
  • Screening of approximately 100,000 small-molecule compounds.
  • Follow-up screens to validate hit compounds for adiponectin-boosting and PPARγ-neutral activity.

Main Results:

  • Identification of six hit compounds that enhance adiponectin secretion.
  • Confirmed absence of PPARγ agonistic activity in the identified compounds.
  • Demonstrated the utility of the HTS assay for discovering adiponectin modulators.

Conclusions:

  • The identified compounds are potential drug candidates for treating diabetes, obesity, atherosclerosis, and other metabolic syndromes.
  • The developed HTS assay is a valuable tool for discovering adipokine modulators.
  • This approach offers a safer alternative to PPARγ agonists for managing metabolic disorders.